Article
Analyses of FGFR3 and PIK3CA mutations in neuroblastomas and the effects of the corresponding inhibitors on neuroblastoma cell lines.
International journal of oncology - 1 Dec 2019
Kostopoulou Ourania N, Holzhauser Stefan, Lange Birthe K A, Ohmayer Anna, Andonova Teodora, Bersani Cinzia, Wickström Malin, Dalianis Tina
Abstract excerpt
Fibroblast growth factor receptor (FGFR)3 and phosphatidylinositol‑4,5‑bisphosphate 3‑kinase, catalytic subunit alpha (PIK3CA) mutations are found in various types of cancer, such as urinary bladder cancer, human papillomavirus‑positive tonsillar and base of the tongue squamous cell carcinoma, breast cancer and some childhood sarcomas. Several drugs can target these genes, some of which have been used for the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
